Does GLASDEGIB Cause Product use issue? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Product use issue have been filed in association with GLASDEGIB (Daurismo). This represents 1.5% of all adverse event reports for GLASDEGIB.
8
Reports of Product use issue with GLASDEGIB
1.5%
of all GLASDEGIB reports
3
Deaths
2
Hospitalizations
How Dangerous Is Product use issue From GLASDEGIB?
Of the 8 reports, 3 (37.5%) resulted in death, 2 (25.0%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLASDEGIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does GLASDEGIB Cause?
Death (102)
Febrile neutropenia (86)
Pneumonia (50)
Off label use (29)
Neoplasm progression (28)
Neutropenia (26)
Electrocardiogram qt prolonged (18)
Sepsis (18)
Pyrexia (17)
Septic shock (16)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which GLASDEGIB Alternatives Have Lower Product use issue Risk?
GLASDEGIB vs GLATIRAMER
GLASDEGIB vs GLECAPREVIR\PIBRENTASVIR
GLASDEGIB vs GLEEVEC
GLASDEGIB vs GLICLAZIDE
GLASDEGIB vs GLIMEPIRIDE